Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, giving promising advancements across different medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, far more trustworthy substitute for therapeutic use, specia